美国 · 经济杂志 · Institutional Investor
Biopharma’s Sickly September
September was a rough month for prominent biopharma and life sciences hedge funds.Many lost money, some by double-digit percentage rates. As a result, quite a few funds are up…
在 Institutional Investor 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.institutionalinvestor.com)



